Cataract  >>  tobramycin/dexamethasone  >>  Phase 3
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tobramycin/dexamethasone / Generic mfg.
NCT00362895: A Bioequivalence Study of Tobradex AF

Completed
3
995
US
Tobramycin 0.3% / Dexamethasone 0.033% ophthalmic suspension, Tobramycin 0.3% / Dexamethasone 0.1% ophthalmic suspension (TOBRADEX), TOBRADEX®
Alcon Research
Cataract
08/06
08/06
NCT00473070: A Clinical Study of Tobradex AF

Completed
3
900
US
Tobradex AF
Alcon Research
Cataract
02/07
 
TBO, NCT02734459: A Bioequivalence Study to Compare the Pharmacokinetics (PK) Of Marketed Product TobraDex® To An Experimental Ophthalmic Sterile Ointment Containing Tobramycin And Dexamethasone In Aqueous Humor In Patients Undergoing Indicated Cataract Surgery

Completed
3
756
RoW
cataract surgery
Semler Research Center Pvt. Ltd., Genzum Life Sciences
Bilateral Cataract
10/15
03/16
LEADER7, NCT03739528 / 2018-000286-36: Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery

Completed
3
808
Europe
Levofloxacin + dexamethasone followed by dexamethasone, Levofloxacin + dexamethasone followed by Maxidex, Tobramycin + Dexamethasone, Tobradex
NTC srl
Cataract
12/18
12/18

Download Options